Long-term Benefits and Harms Associated With Genetic Cholesteryl Ester Transfer Protein Deficiency in the General Population-Reference-Cited by-同舟云学术

Long-term Benefits and Harms Associated With Genetic Cholesteryl Ester Transfer Protein Deficiency in the General Population

Published:2022-01-01 Issue:1 Volume:7 Page:55
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Nordestgaard Liv Tybjærg¹²,Christoffersen Mette¹,Lauridsen Bo Kobberø¹³,Afzal Shoaib²⁴⁵,Nordestgaard Børge Grønne²⁴⁵⁶,Frikke-Schmidt Ruth¹²⁵,Tybjærg-Hansen Anne¹²⁵⁶

Affiliation:

1. Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

2. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

3. Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

4. Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark

5. The Copenhagen General Population Study, Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark

6. The Copenhagen City Heart Study, Bispebjerg and Frederiksberg Hospital, Copenhagen University Hospital, Copenhagen, Denmark

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2784937/jamacardiology_nordestgaard_2021_oi_210065_1640293643.38154.pdf

Reference43 articles.

1. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.;Barter;Arterioscler Thromb Vasc Biol,2003

2. Trials and tribulations of CETP inhibitors.;Tall;Circ Res,2018

3. Effects of torcetrapib in patients at high risk for coronary events.;Barter;N Engl J Med,2007

4. Evacetrapib and cardiovascular outcomes in high-risk vascular disease.;Lincoff;N Engl J Med,2017